In this article well discuss how GST-fusion proteins and glutathione agarose beads are used to perform GST pull-down assays in order to identify protein-protein interactions
Food and Drug Administration (FDA) approval for Rybelsus in the treatment of type 2 diabetes patients who are at risk of the major adverse cardiovascular events (MACE), such as heart attack, stroke, or cardiovascular death
It is believed that reduced concentrations of GLP-1 would result in loss of the pro-kinetic actions of GLP-1 in the colon [Citation26], causing constipation and abdominal discomfort, was further supported by the correlation between this and the intensity of abdominal pain (12)
Continued research in this area is essential to develop effective therapeutic strategies that leverage these metabolic mechanisms
Alternatively, agents from different classessuch as SGLT-2 inhibitors or DPP-4 inhibitorscould be discussed if glycaemic targets allow
Published Phase 2 literature has reported substantial effects on body weight, hepatic fat, and glycemic endpoints in study populations with obesity and type 2 diabetes